{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T12:09:54Z","timestamp":1745582994310},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2020,11,24]]},"DOI":"10.18632\/oncotarget.27820","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T15:52:49Z","timestamp":1606233169000},"page":"4438-4447","source":"Crossref","is-referenced-by-count":5,"title":["Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study"],"prefix":"10.18632","volume":"11","author":[{"given":"Nimrod Adatto","family":"Levy","sequence":"first","affiliation":[{"name":"Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Kern","sequence":"additional","affiliation":[{"name":"Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Shepshelovich","sequence":"additional","affiliation":[{"name":"Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Shibolet","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Hershkoviz","sequence":"additional","affiliation":[{"name":"Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Isakov","sequence":"additional","affiliation":[{"name":"Internal Medicine \u201cT\u201d, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","first-page":"201","article-title":"Histological classification of liver and intrahepatic bile duct cancers in SEER registries","volume":"3","author":"Kleiner","year":"2011","journal-title":"J Registry Manag"},{"key":"2","first-page":"463","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"22","author":"Cameron","year":"1996","journal-title":"Ann Surg"},{"key":"3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma","volume":"14","author":"Gores","year":"2013","journal-title":"Gastroenterology"},{"key":"4","doi-asserted-by":"publisher","first-page":"1073274817729245","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"2","author":"El-Serag","year":"2017","journal-title":"Cancer Control"},{"key":"5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intra- and extrahepatic cholangiocarcinoma in the United States: a population based case-control study","volume":"5","author":"McGlynn","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"10","author":"Hong","year":"2010","journal-title":"Cancer Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1478-3231.2009.02149.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China","volume":"3","author":"Zhang","year":"2010","journal-title":"Liver Int"},{"key":"8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"5","author":"Patel","year":"2012","journal-title":"J Hepatol"},{"key":"9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1572-0241.2007.01104.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study","volume":"10","author":"Hassan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10","doi-asserted-by":"publisher","first-page":"e0186643","DOI":"10.1371\/journal.pone.0186643","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare","volume":"1","author":"McGlynn","year":"2017","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis","volume":"14","author":"Pawlik","year":"2014","journal-title":"JAMA Surg"},{"key":"12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1477-2574.2010.00242.x","article-title":"Surgical treatment of intrahepatic cholangiocarcinoma: outcomes and predictive factors","volume":"1","author":"Billingsley","year":"2011","journal-title":"HPB (Oxford)"},{"key":"13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4174\/astr.2020.98.3.116","article-title":"Prognostic factors predicting survival rate over 10 years of patients with intrahepatic cholangiocarcinoma after hepatic resection","volume":"9","author":"Lee","year":"2020","journal-title":"Ann Surg Treat Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11605-011-1419-8","article-title":"Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment","volume":"1","author":"Chen","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"24","author":"Abou-Alfa","year":"2008","journal-title":"Ann Surg"},{"key":"16","doi-asserted-by":"publisher","first-page":"75627","DOI":"10.18632\/oncotarget.18465","article-title":"Prognostic analysis of radical resection for intrahepatic cholangiocarcinoma: a retrospective cohort study","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"17","first-page":"6543423","article-title":"Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection","volume":"201","author":"Xia","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MEG.0000000000001036","article-title":"Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center","volume":"3","author":"Strobel","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12885-020-07051-5","article-title":"Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis","volume":"2","author":"Pan","year":"2020","journal-title":"BMC Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1002\/cncr.28312","article-title":"Multidisciplinary approaches to intrahepatic cholangiocarcinoma","volume":"11","author":"Pawlik","year":"2013","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jso.24093","article-title":"Multimodality treatment of intrahepatic cholangiocarcinoma: A review","volume":"11","author":"Martinie","year":"2016","journal-title":"J Surg Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","article-title":"Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models","volume":"22","author":"Jarnagin","year":"2016","journal-title":"J Am Coll Surg"},{"key":"23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-018-0912-x","article-title":"Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence","volume":"1","author":"Chen","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"24","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.3748\/wjg.v13.i30.4056","article-title":"Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management","volume":"1","author":"Thuluvath","year":"2007","journal-title":"World J Gastroenterol"},{"key":"25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s1072-7515(00)00700-6","article-title":"Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma","volume":"19","author":"Amano","year":"2000","journal-title":"J Am Coll Surg"},{"key":"26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/00001503-200112000-00018","article-title":"Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery","volume":"1","author":"Plevak","year":"2001","journal-title":"Curr Opin Anaesthesiol"},{"key":"27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jamcollsurg.2007.02.067","article-title":"Morbidity and mortality after liver resection: results of the patient safety in surgery study","volume":"20","author":"Tanabe","year":"2007","journal-title":"J Am Coll Surg"},{"key":"28","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/annonc\/mdq650","article-title":"A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score","volume":"2","author":"Chen","year":"2011","journal-title":"Ann Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"3","author":"Shen","year":"2013","journal-title":"J Clin Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma","volume":"24","author":"Schulick","year":"2007","journal-title":"Ann Surg"},{"key":"31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients","volume":"14","author":"Torzilli","year":"2012","journal-title":"Arch Surg"},{"key":"32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.hpb.2018.05.017","article-title":"Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma","volume":"2","author":"Koerkamp","year":"2018","journal-title":"HPB (Oxford)"},{"key":"33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"8","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"34","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Schwabe","year":"2013","journal-title":"Nat Commun"},{"key":"35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer","volume":"1","author":"Schwabe","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"36","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"2","author":"Poulsen","year":"1995","journal-title":"J Hepatol"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3656-4_14","article-title":"Liver (Including Intrahepatic Bile Ducts)","author":"Morrow","year":"2002","journal-title":"AJCC Cancer Staging Manual"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T15:53:43Z","timestamp":1606233223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":37,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2020,11,24]]}},"alternative-id":["27820"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27820","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}